SEARCH

SEARCH BY CITATION

References

  • Akabayashi A., Zaia C. T., Gabriel S. M., Silva I., Cheung W. K. and Leibowitz S. F. (1994) Intracerebroventricular injection of dibutyryl cyclic adenosine 3′,5′-monophosphate increases hypothalamic levels of neuropeptide Y. Brain Res. 660, 323328.
  • Alexander M., Rothman R. B., Baumann M. H., Endres C. J., Brasic J. R. and Wong D. F. (2005) Noradrenergic and dopaminergic effects of (+)-amphetamine-like stimulants in the baboon Papio anubis. Synapse 56, 9499.
  • Andersson M., Konradi C. and Cenci M. A. (2001) cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum. J. Neurosci. 21, 99309943.
  • Borovicka M. C., Fuller M. A., Konicki P. E., White J. C., Steele V. M. and Jaskiw G. E. (2002) Phenylpropanolamine appears not to promote weight loss in patients with schizophrenia who have gained weight during clozapine treatment. J. Clin. Psychiatry 63, 345348.
  • Brenhouse H. C., Howe M. L. and Stellar J. R. (2007) Differential activation of cAMP response element binding protein in discrete nucleus accumbens subregions during early and late cocaine sensitization. Behav. Neurosci. 121, 212217.
  • Chance W. T., Sheriff S. and Balasubramaniam A. (2000) Antagonism of NPY-induced feeding by pretreatment with cyclic AMP response element binding protein antisense oligonucleotide. Neuropeptides 34, 167172.
  • Chen P. N., Chu S. C., Chiou H. L., Kuo W. H., Chiang C. L. and Hsieh Y. S. (2006) Mulberry anthocyanins, cyanidin 3-rutinoside and cyaniding 3-glucoside, exhibited an inhibitory effect on the migration and invasion of a human lung cancer cell line. Cancer Lett. 235, 248259.
  • Cheng J. T. and Kuo D. Y. (2003) Both α1-adrenergic and D1-dopaminergic neurotransmissions are involved in phenylpropanolamine-mediated feeding suppression in mice. Neurosci. Lett. 347, 136138.
  • Chiasson B. J., Hooper M. L., Murphy P. R. and Robertson H. A. (1992) Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain. Eur. J. Pharmacol. 227, 451453.
  • Choi K. H., Whisler K., Graham D. L. and Self D. W. (2006) Antisense-induced reduction in nucleus accumbens cyclic AMP response element binding protein attenuates cocaine reinforcement. Neuroscience 137, 373383.
  • Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid quanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156159.
  • Colman E. (2005) Anorectics on trial: a half century of federal regulation of prescription appetite suppressants. Ann. Intern. Med. 143, 380385.
  • Cooper T. V., Klesges R. C., Debon M. W., Zbikowski S. M., Johnson K. C. and Clemens L. H. (2005) A placebo controlled randomized trial of the effects of phenylpropanolamine and nicotine gum on cessation rates and postcessation weight gain in women. Addict. Behav. 30, 6175.
  • Das S., Grunert M., Williams L. and Vincent S. R. (1997) NMDA and D1 receptors regulate the phosphorylation of CREB and the induction of c-fos in striatal neurons in primary culture. Synapse 25, 227233.
  • Diepvens K., Westerterp K. R. and Westerterp-Plantenga M. S. (2007) Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R77R85.
  • Dominguez G. and Kuhar M. J. (2004) Transcriptional regulation of the CART promoter in CATH.a cells. Brain Res. Mol. Brain Res. 126, 2229.
  • Ghosh M. K. and Cohen J. S. (1992) Oligodeoxynucleotides as antisense inhibitors of gene expression. Prog. Nucl. Acid Res. Mol. Biol. 42, 79126.
  • Griffioen G. and Thevelein J. M. (2002) Molecular mechanisms controlling the localization of protein kinase A. Curr. Genet. 41, 199207.
  • Habener J. F., Miller C. P. and Vallejo M. (1995) cAMP-dependent regulation of gene transcription by cAMP response element-binding protein and cAMP response element modulator. Vitam. Horm. 51, 157.
  • Hsieh Y. S., Hsu J. D., Yang S. F. and Kuo D. Y. (2004) Immunohistochemical and genomic evidence for the involvement of hypothalamic neuropeptide Y in phenylpropranolamine-mediated appetite suppression. Peptides 25, 21552161.
  • Hsieh Y. S., Yang S. F., Chiou H. L. and Kuo D. Y. (2005) Transcriptional involvement of protein kinase C-alpha isozyme in amphetamine-mediated appetite suppression. Eur. J. Neurosci. 22, 715723.
  • Hsieh Y. S., Yang S. F., Chiou H. L. and Kuo D. Y. (2006) Activations of c-fos/c-jun signaling are involved in the modulation of hypothalamic superoxide dismutase (SOD) and neuropeptide Y (NPY) gene expression in amphetamine-mediated appetite suppression. Toxicol. Appl. Pharm. 212, 99109.
  • Hsieh Y. S., Yang S. F. and Kuo D. Y. (2007) Intracerebral administration of protein kinase A or c-AMP response element binding protein antisense oligonucleotide can modulate amphetamine-mediated appetite suppression in free-moving rats. Am. J. Physiol. Endoc. Metab. 292, 123131.
  • Hu D., Cao P., Thiels E., Chu C. T., Wu G. Y., Oury T. D. and Klann E. (2007) Hippocampal long-term potentiation, memory, and longevity in mice that overexpress mitochondrial superoxide dismutase. Neurobiol. Learn. Mem. 87, 372384.
  • Hull K. M., Sanderson W. D. and Maher T. J. (1993) Effect of phenylpropanolamine and related compounds on beta-adrenoceptor-induced activation of adenylyl cyclase. Life Sci. 52, 12871294.
  • Hulsey M. G., Pless C. M., White B. D. and Martin R. J. (1995) ICV administration of anti-NPY antisense oligonucleotide: effects on feeding behavior, body weight, peptide content and peptide release. Regul. Peptides 59, 207214.
  • Jones D. C. and Kuhar M. J. (2006) Cocaine-amphetamine-regulated transcript expression in the rat nucleus accumbens is regulated by adenylyl cyclase and the cyclic adenosine 5′-monophosphate/protein kinase a second messenger system. J. Pharmacol. Exp. Ther. 317, 454461.
  • Kacew S., Narbaitz R. and Stevenson A. J. (1977) The effects of chlorphentermine and phentermine on certain metabolic parameters associated with development of rat kidney and liver. Chem. Biol. Interact. 19, 6176.
  • Konradi C., Cole R. L., Heckers S. and Hyman S. E. (1994) Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J. Neurosci. 14, 56235634.
  • Lambert P. D., Couceyro P. R., McGirr K. M., Dall Vechia S. E., Smith Y. and Kuhar M. J. (1998) CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse 29, 293298.
  • Larhammar D., Ericsson A. and Persson H. (1987) Structure and expression of the rat neuropeptide Y gene. Proc. Natl Acad. Sci. USA 84, 20682072.
  • Levin O. S. (2005) ‘Ephedron’ encephalopathy. Zh. Nevrol. Psikhiatr. Im. S S Korsakova (Russ.) 105, 1220.
  • Magni P. and Barnea A. (1992) Forskolin and phorbol ester stimulation of neuropeptide Y (NPY) production and secretion by aggregating fetal brain cells in culture: evidence for regulation of NPY biosynthesis at transcriptional and posttranscriptional levels. Endocrinology 130, 976984.
  • McDaid J., Graham M. P. and Napier T. C. (2006) Methamphetamine-induced sensitization differentially alters pCREB and δFosB throughout the limbic circuit of the mammalian brain. Mol. Pharmacol. 70, 20642074.
  • Morris B. J. (1989) Neuronal localization of neuropeptide Y gene expression in rat brain. J. Comp. Neurol. 290, 358368.
  • Nair A. and Vaidya V. A. (2006) Cyclic AMP response element binding protein and brain-derived neurotrophic factor: molecules that modulate our mood? J. Biosci. 31, 423434.
  • Nelson D. L. and Gehlert D. R. (2006) Central nervous system biogenic amine targets for control of appetite and energy expenditure. Endocrine 29, 4960.
  • Ogawa S. and Pfaff D. W. (1998) Current status of antisense DNA methods in behavioral studies. Chem. Senses 23, 249255.
  • Ogawa S., Brown H. E., Okano H. J. and Pfaff D. W. (1995) Cellular uptake of intracerebrally administered oligodeoxynucleotides in mouse brain. Regul. Peptides 59, 143149.
  • Pandey S. C. (2003) Anxiety and alcohol abuse disorders: a common role for CREB and its target, the neuropeptide Y gene. Trends Pharmacol. Sci. 24, 456460.
  • Paxinos G. and Watson C.(1986) The rat Brain in Stereotaxic Coordinates, 2nd Edn. Academic Press, Sydney, NSW.
  • Richard D. (1995) Exercise and the neurobiological control of food intake and energy expenditure. Int. J. Obes. 19, S73S79.
  • Ritter R. C., Slusser P. G. and Stone S. (1981) Glucoreceptors controlling feeding and blood glucose: location in the hindbrain. Science 213, 451452.
  • Saito S. Y., Maruyama Y., Kamiyama S., Nakahata N. and Ohizumi Y. (2004) Ephedrae herba in Mao-Bushi-Saishin-To inhibits IgE-mediated histamine release and increases cAMP content in RBL-2H3 cells. J. Pharmacol. Sci. 95, 4146.
  • Schteingart D. E. (1992) Effectiveness of phenylpropanolamine in the management of moderate obesity. Int. J. Obes. 16, 487493.
  • Scott L., Leddy M., Bernay F. and Davot J. L. (2002) Evaluation of phenylpropanolamine in the treatment of urethral sphincter mechanism incompetence in the bitch. J. Small Anim. Pract. 43, 493496.
  • Sheng P., Wang X. B., Ladenheim B., Epstein C. and Cadet J. L. (1996) AP-1 DNA-binding activation by methamphetamine involves oxidative stress. Synapse 24, 213217.
  • Sheriff S., Chance W. T., Fischer J. E. and Balasubramaniam A. (1997) Neuropeptide Y treatment and food deprivation increase cyclic AMP response element-binding in rat hypothalamus. Mol. Pharmacol. 51, 597604.
  • Sheriff S., Chance W. T., Iqbal S., Rizvi T. A., Xiao C., Kasckow J. W. and Balasubramaniam A. (2003) Hypothalamic administration of cAMP agonist/PKA activator inhibits both schedule feeding and NPY-induced feeding in rats. Peptides 24, 245254.
  • Shimizu-Albergine M., Ippolito D. L. and Beavo J. A. (2001) Downregulation of fasting-induced cAMP response element-mediated gene induction by leptin in neuropeptide Y neurons of the arcuate nucleus. J. Neurosci. 21, 12381246.
  • Wellman P. J. and Davies B. T. (1992) Reversal of cirazoline- and phenylpropanolamine-induced anorexia by the α1-adrenergic receptor antagonist prazosin. Pharmacol. Biochem. Behav. 42, 97100.
  • Widnell K. L., Self D. W., Lane S. B., Russell D. S., Vaidya V., Miserendino M. J. D., Rubin C. S., Duman R. S. and Nestler E. J. (1996) Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens. J. Pharmacol. Exp. Ther. 276, 306315.
  • Williams G., Bing C., Cai X. J., Harrold J. A., King P. J. and Liu X. H. (2001) The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol. Behav. 74, 683701.
  • Wynne K., Stanley S., McGowan B. and Bloom S. (2005) Appetite control. J. Endocrinol. 184, 291318.
  • Yee F., Ericson H., Reis D. J. and Wahlestedt C. (1994) Cellular uptake of intracerebroventricularly administered biotin- or digoxigenin-labeled antisense oligodeoxynucleotides in the rat. Cell. Mol. Neurobiol. 14, 475486.
  • Zhang M. and Creese I. (1993) Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates. Neurosci. Lett. 161, 223226.